reaction ( fig. 1 ). In the 3 patients who had undergone ELS treatment within 12 months of LTX, deposits of hyalonoid amorphous material, indicative of residual foam sealant, were detected within alveoli ( fig. 2 ). There were no signs of tissue necrosis or dysplasia. Note, there were no histological features of fibrosis in the treatment sites or in adjacent areas. This is the first report in humans of the long-term histological effects of BLVR using ELS therapy. Despite the fact that our conclusions are based on a small number of patients, this histological confirmation regarding the long-term effects of the administered sealant adds important data regarding its safety profile.
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The clinical safety and efficacy of bronchoscopic lung volume reduction (BLVR) using bilateral emphysematous lung sealant (ELS) treatment in patients with endstage emphysema has previously been demonstrated [1, 2] . However, scant data are available regarding the longterm histological effects of ELS treatment on lung tissue.
Out of 70 patients who received ELS treatment at our center, 5 (aged 56-67 years) subsequently underwent lung transplantation (LTX). The time from BLVR to LTX ranged from 9 to 24 months (median 10 months). In these patients, BLVR served as a bridge to LTX, as their quality of life did not improve significantly following the procedure.
Explanted lungs were harvested and sectioned tissue blocks examined by light microscopy. In all 5 patients, a similar histological pattern at the treatment sites was noted consisting of focal non-necrotizing granulomatous inflammation containing epitheliod cell granulomas and Langerhan's type giant cells indicative of a foreign body 
